Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.

Tuesday, 08 December 2020 05:20

SCHOTT MINIFAB - IVD Microfluidics Webinar

What does it take to create a successful microfluidic diagnostic device? Learn from the world leaders in both glass and polymer. 9am CET 18 December 2020. Limited places so register now.

TearLab® Corporation, together with SCHOTT MINIFAB are celebrating an important milestone with the delivery of the 20 millionth microfluidic eye test card from the production line in Melbourne, Australia. The milestone comes as a result of a 13-year contract manufacturing partnership between the two companies, beginning in 2007 with an ambitious microfluidic product development program.

When it comes to managing and mitigating product development risk, there are six guiding principles that are proven to work.

Monday, 08 June 2020 01:30

MINIFAB rebrands to SCHOTT MINIFAB

Market leader in microfluidic device manufacture has re-branded from MINIFAB to SCHOTT MINIFAB. The change of name and visual re-brand comes after SCHOTT AG acquired the company in July 2019 and forms one part of an ongoing integration process.

Taking a long-term view at the outset of the cartridge development program is critical for reducing the cost of goods (COGS) when the time inevitably comes to ramp up manufacturing volume.

Page 1 of 2